Italian Validation of Neurogenic Dysphagia Assessment Tools
ClinicalTrials.gov Studies
Summary
This observational clinical trial (NCT07549724) aims to translate and validate Italian versions of clinical assessment tools for patients with neurogenic dysphagia. The instruments include the New Zealand Secretion Severity Scale, the Reflex Cough Test, the VASES scale used during fiberoptic endoscopic evaluation of swallowing, and the Drooling Severity Scale. The study will enroll approximately 100 patients with neurogenic dysphagia to provide reliable, standardized tools in Italian for clinicians assessing swallowing and oral-motor function in patients with neurological disorders.
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
This observational study registered on ClinicalTrials.gov describes a translation and validation effort for Italian versions of four clinical assessment tools used to evaluate neurogenic dysphagia: the New Zealand Secretion Severity Scale, the Reflex Cough Test, the VASES scale, and the Drooling Severity Scale. The study plans to include approximately 100 patients with neurogenic dysphagia.
For healthcare providers and clinical researchers, this registration represents an upcoming resource for standardized dysphagia assessment in Italian-speaking patient populations. The validation of these tools may support future clinical practice for neurologists, speech-language pathologists, and other specialists treating patients with neurological disorders affecting swallowing function.
Archived snapshot
Apr 25, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Clinical and Instrumental Assessment Tools for Neurogenic Dysphagia: Translation and Validation
Observational NCT07549724 Kind: OBSERVATIONAL Apr 24, 2026
Abstract
This study aims to translate and validate Italian versions of several clinical assessment tools for patients with neurogenic dysphagia. The instruments include:
The New Zealand Secretion Severity Scale, which evaluates secretion management; The Reflex Cough Test from the I&I cranial nerves assessment; The VASES scale used during fiberoptic endoscopic evaluation of swallowing; The Drooling Severity Scale, which measures saliva control.
The study will include approximately 100 patients with neurogenic dysphagia. The goal is to provide reliable, standardized tools in Italian to support clinicians in assessing swallowing and oral-motor function in patients with neurological disorders.
Conditions: Dysphagia
Interventions: dysphagia assessment
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.